Earnings History Data for Glaukos Corporation (GKOS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Glaukos Corporation

Glaukos Corporation is an ophthalmic medical technology company. The Company develops, manufactures and markets medical devices for the treatment of glaucoma. Its product pipeline consists of iStent Inject, the iStent Supra and iDose. The company operates primarily in United States, Germany, Europe, the Asia Pacific, Canada and internationally. Glaukos Corporation is headquartered in Laguna Hills, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
04-11-2024	AH		GKOS	Glaukos Corporation	7,270	-0.28	-0.52	-0.50	Glaukos Non-GAAP EPS of -$0.28 beats by $0.20, revenue of $96.67M beats by $5.2M [11/4/2024 4:56 PM]	127.75	-3.63 (-2.76%)	122.01	-9.37 (-7.13%)	59.22 - 139.51	1,481,164	510,000	1,708
Glaukos Non-GAAP EPS of -$0.28 beats by $0.20, revenue of $96.67M beats by $5.2M [11/4/2024 4:56 PM] Earnings To Watch: Glaukos Corp (GKOS) Reports Q3 2024 Result [Nov-01-24 09:01AM] Glaukos: Q3 Earnings Snapshot [2024-11-04 04:25PM] Glaukos Announces Third Quarter 2024 Financial Results [2024-11-04 04:05PM]
31-07-2024	AH		GKOS	Glaukos Corporation	6,030	-0.52	-0.52	-0.55	Glaukos reports mixed Q2 results; raises FY24 revenue outlook [7/31/2024 5:37 PM]	118.12	0.95 (0.81%)	108.95	-8.22 (-7.02%)	59.22 - 126.96	1,110,095	620,000	2,634
Glaukos reports mixed Q2 results; raises FY24 revenue outlook [7/31/2024 5:37 PM]
01-05-2024	AH		GKOS	Glaukos Corporation	4,810	-0.70	-0.59	-0.59	Glaukos Non-GAAP EPS of -$0.70 misses by $0.13, revenue of $85.6M beats by $5.94M [5/1/2024 5:12 PM]	104.80	5.89 (5.95%)	97.00	-1.91 (-1.93%)	45.38 - 108.22	686,664	460,000	13,408
Glaukos Non-GAAP EPS of -$0.70 misses by $0.13, revenue of $85.6M beats by $5.94M [5/1/2024 5:12 PM]
21-02-2024	AH		GKOS	Glaukos Corporation	4,520	-0.63	-0.56	-0.53	Glaukos Non-GAAP EPS of -$0.63 misses by $0.08, revenue of $82.37M beats by $3.84M [2/21/2024 4:42 PM]	91.69	-1.11 (-1.19%)	92.79	0.0 (0.00%)	44.26 - 97.24	833,723	460,000	13,727
Glaukos Non-GAAP EPS of -$0.63 misses by $0.08, revenue of $82.37M beats by $3.84M [2/21/2024 4:42 PM]
01-11-2023	AH		GKOS	Glaukos Corporation	3,250	-0.50	-0.56	-0.45	Glaukos Non-GAAP EPS of -$0.50 beats by $0.05, revenue of $78M beats by $2.73M [11/1/2023 4:55 PM]	64.17	-5.26 (-7.58%)	64.17	0.0 (0.00%)	40.45 - 80.28	1,963,807	520,000	1,791
Glaukos Non-GAAP EPS of -$0.50 beats by $0.05, revenue of $78M beats by $2.73M [11/1/2023 4:55 PM]
02-08-2023	AH		GKOS	Glaukos Corporation	3,720	-0.55	-0.57	-0.83	Glaukos Non-GAAP EPS of -$0.55 beats by $0.01, revenue of $80.4M beats by $5.74M [8/2/2023 5:11 PM]	74.33	-0.39 (-0.52%)	74.72	0.0 (0.00%)	40.45 - 80.28	436,611	580,000	13,067
Glaukos Non-GAAP EPS of -$0.55 beats by $0.01, revenue of $80.4M beats by $5.74M [8/2/2023 5:11 PM]
03-05-2023	AH	4:05 PM ET (May 3)	GKOS	Glaukos Corporation	2,280	-0.59	-0.61	-0.38	Glaukos Non-GAAP EPS of -$0.59 misses by $0.01, revenue of $73.9M beats by $6.16M [5/3/2023 4:37 PM]	50.55	4.09 (8.79%)	46.46	0.0 (0.00%)	33.33 - 60.92	604,737	250,000	14,658
Glaukos Non-GAAP EPS of -$0.59 misses by $0.01, revenue of $73.9M beats by $6.16M [5/3/2023 4:37 PM]
22-02-2023	AH	4:05 PM ET (Feb 22)	GKOS	Glaukos Corporation	2,460	-0.53	-0.56	-0.31	Glaukos Non-GAAP EPS of -$0.53 beats by $0.02, revenue of $71.22M beats by $3.15M [2/22/2023 4:15 PM]	49.09	-1.34 (-2.66%)	47.82	-2.61 (-5.18%)	33.33 - 64.49	903,652	360,000	1,291
Glaukos Non-GAAP EPS of -$0.53 beats by $0.02, revenue of $71.22M beats by $3.15M [2/22/2023 4:15 PM]
02-11-2022	AH	4:05 PM ET (Nov 2)	GKOS	Glaukos Corporation	2,670	-0.45	-0.53	-0.19	Glaukos Q3 results beat estimates, co tightens FY 2022 net sales guidance [11/2/2022 4:40 PM]	48.39	-5.02 (-9.40%)	53.41	0.0 (0.00%)	33.33 - 64.49	1,248,545	330,000	9,269
Glaukos Q3 results beat estimates, co tightens FY 2022 net sales guidance [11/2/2022 4:40 PM] Glaukos Corporation Announces Third Quarter 2022 Financial Results [Nov-02-22 04:05PM] Glaukos (GKOS) Reports Q3 Loss, Tops Revenue Estimates [Nov-02-22 06:35PM]
03-08-2022	AH	4:05 PM ET (Aug 3)	GKOS	Glaukos Corporation	2,370	-0.83	-0.44	-0.11	Glaukos Non-GAAP EPS of -$0.83 misses by $0.39, revenue of $72.69M beats by $4.7M [8/3/2022 4:51 PM]	53.62	0.27 (0.51%)	53.00	-0.35 (-0.66%)	33.33 - 64.49	1,221,043	480,000	105
Glaukos Non-GAAP EPS of -$0.83 misses by $0.39, revenue of $72.69M beats by $4.7M [8/3/2022 4:51 PM] Glaukos Corporation Announces Second Quarter 2022 Financial Results [Aug-03-22 04:05PM] Glaukos Announces FDA 510(k) Clearance of iStent infinite® [Aug-03-22 04:05PM] The Zacks Analyst Blog Highlights McKesson, AmerisourceBergen, LHC Group and Glaukos [Aug-03-22 09:07AM] Medical Device Stocks' Earnings on Aug 3: MCK, ABC & More [Aug-02-22 10:09AM]
04-05-2022	AH	4:05 PM ET (May 4)	GKOS	Glaukos	2,237	-0.38	-0.52	0.00	Glaukos Non-GAAP EPS of -$0.38 beats by $0.13, revenue of $67.7M beats by $6.85M [5/4/2022 4:16 PM]	44.85	-2.65 (-5.59%)	47.51	0.0 (0.00%)	39.35 - 92.48	911,412	660,000	99,400
Glaukos Non-GAAP EPS of -$0.38 beats by $0.13, revenue of $67.7M beats by $6.85M [5/4/2022 4:16 PM] Glaukos (NYSE:GKOS) Has Debt But No Earnings; Should You Worry? [May-03-22 11:13AM] Glaukos Corporation Announces First Quarter 2022 Financial Results [May-04-22 04:05PM] Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates [May-04-22 06:45PM]
22-02-2022	AH	4:10 PM ET (Feb 22)	GKOS	Glaukos Corporation	2,450	-0.31	-0.37	-0.02	Glaukos Non-GAAP EPS of -$0.31 beats by $0.06, revenue of $73.2M beats by $5.93M [2/22/2022 4:13 PM]	50.98	1.91 (3.89%)	51.00	1.93 (3.93%)	39.35 - 99.00	751,440	360,000	10,485
Glaukos Non-GAAP EPS of -$0.31 beats by $0.06, revenue of $73.2M beats by $5.93M [2/22/2022 4:13 PM] Glaukos Corporation Announces Fourth Quarter and Full Year 2021 Financial Results [Feb-22-22 04:05PM] Glaukos (GKOS) Reports Q4 Loss, Tops Revenue Estimates [Feb-22-22 06:15PM] Glaukos (GKOS) Q4 Earnings and Revenues Surpass Estimates [Feb-23-22 11:07AM]
04-11-2021	AH	4:10 PM ET (Nov 4)	GKOS	Glaukos Corporation	2,160	-0.19	-0.23	-0.09	Glaukos EPS beats by $0.03, beats on revenue [11/4/2021 5:18 PM]	56.99	1.98 (3.60%)	53.50	-1.51 (-2.74%)	42.69 - 99.00	514,047	770,000	571
Glaukos EPS beats by $0.03, beats on revenue [11/4/2021 5:18 PM] Why Glaukos Stock Is Soaring Today [Nov-03-21 12:39PM] Why Are Glaukos Shares Rallying Today? [Nov-03-21 11:54AM] 25 Stocks Moving in Wednesday's Pre-Market Session [Nov-03-21 07:03AM] Glaukos Stock Jumps After Upgrade on Medicare Reimbursement Rules [Nov-03-21 05:59AM] Glaukos Corporation Announces Third Quarter 2021 Financial Results [Nov-04-21 04:10PM] Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday [Nov-03-21 07:30AM] Glaukos (GKOS) Reports Q3 Loss, Tops Revenue Estimates [Nov-04-21 06:45PM]
05-08-2021	AH	4:10 PM ET (Aug 5)	GKOS	Glaukos Corporation	2,290	-0.11	-0.24	-0.61	Glaukos EPS beats by $0.14, beats on revenue; issues guidance [8/5/2021 4:54 PM]	50.95	-0.01 (-0.02%)	46.73	-4.23 (-8.30%)	40.08 - 99.00	1,200,355	560,000	83,630
Glaukos Corporation Announces Second Quarter 2021 Financial Results [Aug-05-21 04:10PM] Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates [Aug-05-21 05:55PM] Glaukos Corp (GKOS) Q2 2021 Earnings Call Transcript [Aug-06-21 02:30PM]
05-05-2021	AH	4:10 PM ET (May 5)	GKOS	Glaukos Corporation	4,350	-0.21	-0.30	-0.44	Glaukos EPS beats by $0.10, beats on revenue [5/5/2021 4:38 PM]	82.63	-7.81 (-8.64%)	90.44	0.0 (0.00%)	34.10 - 99.00	929,133	330,000	6,608
Glaukos Corp. to Host Earnings Call [May-05-21 02:45PM] Glaukos Corporation Announces First Quarter 2021 Financial Results [May-05-21 04:10PM] Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates [May-05-21 06:35PM] Glaukos Corp (GKOS) Q1 2021 Earnings Call Transcript [May-05-21 08:01PM]
25-02-2021	AH	4:10 PM ET (Feb 25)	GKOS	Glaukos Corporation	4,230	-0.02	-0.32	-0.06	Glaukos EPS beats by $0.27, beats on revenue [2/25/2021 4:24 PM]	94.80	2.69 (2.92%)	92.11	0.0 (0.00%)	23.31 - 98.24	369,131	436,387	7,520
Glaukos EPS beats by $0.27, beats on revenue [2/25/2021 4:24 PM] Glaukos' late-stage iLink therapy study meets meets main goal [2/25/2021 4:20 PM] Glaukos (GKOS) Q4 Earnings and Revenues Surpass Estimates [Feb-26-21 09:26AM] Glaukos (GKOS) Reports Q4 Loss, Tops Revenue Estimates [Feb-25-21 06:15PM] Glaukos Corporation Announces Fourth Quarter and Full Year 2020 Financial Results [Feb-25-21 04:10PM] Glaukos Announces Positive Phase 3 Trial Results for iLink Epi-on Investigational Therapy That Met the Primary Efficacy Endpoint [Feb-25-21 04:05PM] Glaukos Corp. to Host Earnings Call [Feb-25-21 02:30PM]
05-11-2020	AH	4:10 PM ET (Nov 5)	GKOS	Glaukos Corporation	2,470	-0.09	-0.46	-0.10	Glaukos EPS beats by $0.39, beats on revenue [11/5/2020 5:26 PM]	60.00	3.50 (6.19%)	57.50	1.00 (1.77%)	23.31 - 70.96	817,153	688,406	4,511

06-08-2020	AH	4:10 PM ET (Aug 6)	GKOS	Glaukos Corporation	2,070	-0.61	-0.78	-0.11	Glaukos EPS beats by $0.18, beats on revenue [8/6/2020 4:27 PM]	44.84	-4.26 (-8.67%)	49.09	0.0 (0.00%)	23.31 - 76.06	401,858	574,575	5,459